By conjugating therapeutic peptides to these bone-targeting sequences, they can achieve higher local concentrations at the exact site where healing is needed while minimizing systemic exposure
Here are the most notable findings reported by the studys authors [12]: Selank appears to have similar efficacy in reducing symptoms of GAD as the established anxiolytic medazepam
It is an unlicensed experimental peptide with no established safety or efficacy data in humans
doi: 10.1155/2011/260482 [DOI] [PMC free article] [PubMed] [Google Scholar] 22.Helmerhorst HJ, Schultz MJ, van der Voort PH, de Jonge E, van Westerloo DJ
So why, then, would we use Methionine (thought to activate mTOR) in our B12/MIC formulation
A single miscalculation in bacteriostatic water ratios can compromise months of research, waste expensive peptide vials, or produce inconsistent experimental results